Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bronchopulmonary dysplasia
(
BPD
) is among the most severe complications of very premature birth. Clinical and laboratory studies indicate that lung
immaturity
, inflammatory lung injury, and disordered lung repair are the primary mechanisms responsible for the development of
BPD
. Caffeine, initiated within the first 10 days after birth, is one of few drug therapies shown to significantly decrease the risk of
BPD
in very low birth weight infants. This benefit is likely derived, at least in part, from reduced exposure to positive airway pressure and supplemental oxygen with caffeine therapy. Additional cardiorespiratory benefits of caffeine that may contribute to the lower risk of
BPD
include less frequent treatment for a PDA, improved pulmonary mechanics, and direct effects on pulmonary inflammation, alveolarization, and angiogenesis. Routine administration of caffeine is indicated in the vast majority of very low birth weight infants. However, current preventative strategies including widespread use of caffeine do not avert
BPD
in all cases. As such, there is continued need for novel methods to further reduce the risk of
BPD
in very low birth weight infants.
...
PMID:What is bronchopulmonary dysplasia and does caffeine prevent it? 3316 65
<< Previous
1
2
3
4
5
6
7
